Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Analysts Estimate Johnson & Johnson Can Outperform Pfizer Over Next 5 Years
Analysts Estimate Johnson & Johnson Can Outperform Pfizer Over Next 5 Years
Analysts Estimate Johnson & Johnson Can Outperform Pfizer Over Next 5 Years
Submitted by
admin
on May 17, 2011 - 8:53pm
Source:
Seeking Alpha
News Tags:
Pfizer
JNJ
Headline:
Analysts Estimate Johnson & Johnson Can Outperform Pfizer Over Next 5 Years
Do Not Allow Advertisers to Use My Personal information
